[HTML][HTML] The transmembrane protease TMPRSS2 as a therapeutic target for COVID-19 treatment

L Wettstein, F Kirchhoff, J Münch - International Journal of Molecular …, 2022 - mdpi.com
TMPRSS2 is a type II transmembrane protease with broad expression in epithelial cells of
the respiratory and gastrointestinal tract, the prostate, and other organs. Although the …

Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?

M Depfenhart, D de Villiers, G Lemperle… - Internal and emergency …, 2020 - Springer
Of huge importance now is to provide a fast, cost-effective, safe, and immediately available
pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent …

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

D Bestle, MR Heindl, H Limburg… - Life science …, 2020 - life-science-alliance.org
The novel emerged SARS-CoV-2 has rapidly spread around the world causing acute
infection of the respiratory tract (COVID-19) that can result in severe disease and lethality …

Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells

V Kumar, JK Dhanjal, P Bhargava, A Kaul… - Journal of …, 2022 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) initiated in December 2019 in Wuhan,
China and became pandemic causing high fatality and disrupted normal life calling world …

TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes

H Limburg, A Harbig, D Bestle, DA Stein… - Journal of …, 2019 - journals.asm.org
Cleavage of influenza virus hemagglutinin (HA) by host cell proteases is essential for virus
infectivity and spread. We previously demonstrated in vitro that the transmembrane protease …

Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium

E Böttcher-Friebertshäuser, HD Klenk… - Pathogens and …, 2013 - academic.oup.com
Influenza is an acute infection of the respiratory tract, which affects each year millions of
people. Influenza virus infection is initiated by the surface glycoprotein hemagglutinin (HA) …

[HTML][HTML] Airway proteases: an emerging drug target for influenza and other respiratory virus infections

M Laporte, L Naesens - Current Opinion in Virology, 2017 - Elsevier
Highlights•Influenza virus replication depends on activation by airway proteases of the
host.•One prominent enzyme, TMPRSS2, also activates some other respiratory …

TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice

C Tarnow, G Engels, A Arendt, F Schwalm… - Journal of …, 2014 - journals.asm.org
Cleavage of the hemagglutinin (HA) by host proteases is essential for the infectivity of
influenza viruses. Here, we analyzed the role of the serine protease TMPRSS2, which …

The hemagglutinin: a determinant of pathogenicity

E Böttcher-Friebertshäuser, W Garten… - … and Control-Volume I, 2014 - Springer
The hemagglutinin (HA) is a prime determinant of the pathogenicity of influenza A viruses. It
initiates infection by binding to cell surface receptors and by inducing membrane fusion. The …

Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics

W Garten, C Braden, A Arendt, C Peitsch… - European journal of cell …, 2015 - Elsevier
Cellular proteases are reponsible for activation of influenza virus hemagglutinin (HA) in
epithelial tissues of the respiratory tract. The trans-Golgi network (TGN) is the main …